Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kilroy Realty | KRC | Nov 15, 2024 | 38.80 | -1.52 |
Kimball Electronics | KE | Nov 15, 2024 | 19.09 | -2.85 |
Kimbell Royalty Partners LP Units | KRP | Nov 15, 2024 | 15.96 | -2.33 |
Kimberly-Clark | KMB | Nov 15, 2024 | 134.08 | +1.82 |
Kimco Realty | KIM | Nov 15, 2024 | 24.89 | +0.69 |
Kimco Realty L Pref | KIM-L | Nov 15, 2024 | 22.48 | -0.27 |
Kimco Realty M Pref | KIM-M | Nov 15, 2024 | 23.04 | -0.04 |
Kimco Realty Pref ADR | KIM-N | Nov 15, 2024 | 62.52 | +0.19 |
Kinder Morgan | KMI | Nov 15, 2024 | 27.27 | +1.91 |
Kindercare Learning Companies | KLC | Nov 15, 2024 | 23.36 | 0.00 |
Kindly MD | KDLY | Nov 15, 2024 | 0.92 | -0.12 |
Kineta | KA | Nov 15, 2024 | 0.83 | 0.00 |
Kinetik A | KNTK | Nov 15, 2024 | 57.69 | +1.10 |
Kingsoft Cloud ADR | KC | Nov 15, 2024 | 5.05 | +8.60 |
Kingstone Companies | KINS | Nov 15, 2024 | 10.95 | +1.39 |
Kingsway Financial Services | KFS | Nov 15, 2024 | 8.88 | +1.60 |
Kiniksa Pharmaceuticals | KNSA | Nov 15, 2024 | 21.29 | -2.38 |
Kinross Gold | KGC | Nov 15, 2024 | 9.25 | -1.49 |
Kinsale Capital Group | KNSL | Nov 15, 2024 | 465.24 | -1.80 |
Kiora Pharmaceuticals | KPRX | Nov 15, 2024 | 3.29 | -3.15 |
Kirby | KEX | Nov 15, 2024 | 128.04 | -1.47 |
Kirklands | KIRK | Nov 15, 2024 | 1.59 | -1.85 |
Kite Realty Group Trust | KRG | Nov 15, 2024 | 26.69 | -0.56 |
KKR & Co | KKR | Nov 15, 2024 | 150.02 | -0.33 |
KKR Income Opportunities Fund | KIO | Nov 15, 2024 | 13.18 | -0.75 |
KKR Real Estate Finance Trust | KREF | Nov 15, 2024 | 11.26 | -1.66 |
KKR Real Estate Finance Trust A Pref | KREF-A | Nov 15, 2024 | 20.78 | -0.62 |
KLA | KLAC | Nov 15, 2024 | 614.46 | -4.73 |
Klaviyo | KVYO | Nov 15, 2024 | 35.16 | -4.84 |
KLD 400 Social Index Ishares | DSI | Nov 15, 2024 | 111.65 | -1.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.